Skip to Content

Tilray Brands Inc

TLRY: XTSE (CAN)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
CAD 1.90XkyyCcntkfxs

Tilray Earnings: HEXO Acquisition Helps Needed Consolidation, but Canada Remains a Crowded Market

In its third fiscal quarter, no-moat Tilray again suffered from tough Canadian market conditions, plagued by pricing pressures amid too many licensed producers, or LPs, and a stalwart illicit market. Net cannabis revenue grew marginally compared with the second quarter but is about 7% lower year to date compared with the prior-year period. We’ve lowered our full-year fiscal 2023 net revenue forecast about 2% from our prior forecast to $598 million.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of TLRY so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center